COMPANY MISSION: Asieris Pharmaceuticals is a global clinical stage pharmaceutical company specializing in discovering new drugs for the treatment of genitourinary cancer and other major diseases,

On January 7, 2022, Jiangsu Asieris Pharmaceuticals Co., Ltd. (“Asieris Pharmaceuticals”, SHSE: 688176) landed on the Science and Technology Innovation Board (the “STAR Market”) of the

Shanghai, China, Jan. 4, 2022 – Asieris Pharmaceuticals (Asieris), a global innovation-focused pharmaceutical company specializing in new drugs for the treatment of genitourinary tumors, announced today that the

Shanghai, China, December 27, 2021- Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and